We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cambria Tail Risk ETF
TAIL
$146M
| $21.3M | 0.12% |
1,263,622
-28,431
| -2% | -$473K |
|
177
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
| $21.2M | 0.12% |
591,914
-13,804
| -2% | -$535K |
|
178
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.9B
| $21.2M | 0.12% |
822,050
+63,850
| +8% | +$1.84M |
|
179
Thermo Fisher Scientific
TMO
$221B
| $21.2M | 0.12% |
41,797
+1,200
| +3% | +$672K |
|
180
Altria Group
MO
$108B
| $21.1M | 0.12% |
521,983
+10,657
| +2% | +$465K |
|
181
Amgen
AMGN
$225B
| $21.1M | 0.12% |
93,445
+717
| +0.8% | +$174K |
|
182
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
| $21M | 0.12% |
172,581
-74,598
| -30% | -$10.1M |
|
183
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.39B
| $21M | 0.12% |
443,759
+54,607
| +14% | +$2.63M |
|
184
Wells Fargo
WFC
$268B
| $21M | 0.12% |
521,475
+88,730
| +21% | +$3.81M |
|
185
Nuveen ESG Large-Cap Value ETF
NULV
$2.28B
| $20.9M | 0.12% |
677,708
-18,402
| -3% | -$629K |
|
186
iShares 20+ Year Treasury Bond ETF
TLT
$40.7B
| $20.8M | 0.12% |
202,869
+24,001
| +13% | +$2.7M |
|
187
PayPal
PYPL
$50B
| $20.6M | 0.12% |
238,920
+14,288
| +6% | +$1.27M |
|
188
Devon Energy
DVN
$49.4B
| $19.8M | 0.11% |
329,397
+28,557
| +9% | +$1.77M |
|
189
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.48B
| $19.8M | 0.11% |
220,298
-6,211
| -3% | -$588K |
|
190
Target
TGT
$68.9B
| $19.7M | 0.11% |
132,601
-27,953
| -17% | -$4.48M |
|
191
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
| $19.6M | 0.11% |
814,246
+135,348
| +20% | +$3.31M |
|
192
Invesco S&P 500 Pure Value ETF
RPV
$1.72B
| $19.5M | 0.11% |
278,890
-19,284
| -6% | -$1.48M |
|
193
iShares Core S&P US Value ETF
IUSV
$27.8B
| $19M | 0.11% |
303,787
+4,048
| +1% | +$279K |
|
194
Deere & Co
DE
$166B
| $18.8M | 0.11% |
56,260
+4,128
| +8% | +$1.41M |
|
195
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $18.8M | 0.11% |
436,849
+28,019
| +7% | +$1.34M |
|
196
iShares National Muni Bond ETF
MUB
$45.9B
| $18.8M | 0.11% |
183,024
-2,825
| -2% | -$300K |
|
197
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $18.6M | 0.1% |
181,574
-56,087
| -24% | -$6.18M |
|
198
3M
MMM
$93.8B
| $18.5M | 0.1% |
200,570
-4,621
| -2% | -$507K |
|
199
Adobe
ADBE
$102B
| $18.5M | 0.1% |
67,311
-545
| -0.8% | -$206K |
|
200
Capital Group Growth ETF
CGGR
$25.1B
| $18.4M | 0.1% |
942,928
+597,101
| +173% | +$12.8M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.